W2O, an independent network of analytics, marketing and communications companies, has named Rita Glaze as its new practice leader of value, pricing and market access, it was reported yesterday.
In the new role, Glaze will strengthen the group's healthcare commercialisation offering and together with the practice's founder, Brian Reid, she will build a multi-dimensional team to help clients with pricing and reimbursement strategy and communications.
Glaze has 25 years' experience in the biopharmaceutical and life science sector with expertise in marketing, managed markets, pricing strategy and communications. She has held senior positions with organisations such as Takeda, Allscripts and Searle/Pharmacia. Earlier, she has led the network's design and implementation of its US market access communications offering.
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar